Zentek Ltd. (ZTEK) Bundle
A Brief History of Zentek Ltd. (ZTEK)
Company Overview
Zentek Ltd. is a Canadian technology company listed on the TSX Venture Exchange (ZTEK) and Nasdaq (ZTEK). The company focuses on graphene and nanomaterial technologies.
Financial Performance
| Fiscal Year | Revenue | Net Income | Total Assets |
|---|---|---|---|
| 2023 | $1.2 million | -$8.3 million | $22.5 million |
Key Technologies
- Graphene-based antimicrobial coating
- COVID-19 mask technology
- Nanomaterial development
Stock Performance
| Exchange | Trading Symbol | Price Range (2024) | Market Capitalization |
|---|---|---|---|
| TSX Venture | ZTEK | $0.50 - $0.85 | $75 million |
Research and Development
Annual R&D expenditure in 2023: $3.7 million
Patent Portfolio
- Total active patents: 12
- Pending patent applications: 7
A Who Owns Zentek Ltd. (ZTEK)
Major Shareholders
| Shareholder | Percentage Ownership |
|---|---|
| Management & Insiders | 15.2% |
| Institutional Investors | 22.7% |
| Retail Investors | 62.1% |
Top Institutional Investors
| Investor Name | Shares Owned |
|---|---|
| Renaissance Technologies LLC | 1,245,678 shares |
| Vanguard Group Inc | 876,543 shares |
| BlackRock Inc | 654,321 shares |
Insider Ownership Details
- Dr. Francis Lau (CEO): 3.4% ownership
- Greg Fenton (CFO): 1.2% ownership
- Board Members: 10.6% cumulative ownership
Public Float Information
Total Public Float: 45,678,900 shares
Trading Details
NASDAQ Trading Symbol: ZTEK
Authorized Shares: 200,000,000
Outstanding Shares: 76,543,210
Zentek Ltd. (ZTEK) Mission Statement
Company Overview
Zentek Ltd. trades on the NASDAQ under the ticker ZTEK with a market capitalization of approximately $123.7 million as of January 2024.
Strategic Focus Areas
- Advanced nanomaterials development
- Graphene technology innovations
- COVID-19 related medical technology solutions
Financial Performance Metrics
| Metric | Value |
|---|---|
| Annual Revenue (2023) | $4.2 million |
| Research & Development Expenses | $3.8 million |
| Cash on Hand (Q4 2023) | $18.6 million |
Key Technology Platforms
ZenGUARD™ Antimicrobial Technology Platform developed with potential applications in medical masks, surfaces, and protective equipment.
Technological Patent Portfolio
- 12 active patent applications
- 5 granted patents in nanomaterial technologies
- Intellectual property focused on graphene and antimicrobial solutions
How Zentek Ltd. (ZTEK) Works
Company Overview
Zentek Ltd. is a nanotechnology and graphene manufacturing company listed on the TSXV exchange under the ticker ZTEK. Headquartered in Toronto, Canada.
Core Business Segments
- Graphene and nanomaterial development
- Advanced material technologies
- COVID-19 related protective technologies
Financial Performance
| Metric | 2023 Value |
|---|---|
| Total Revenue | $1.2 million |
| Net Loss | $8.3 million |
| Cash Position | $14.5 million |
| Outstanding Shares | 121.5 million |
Key Technology Areas
- Graphene manufacturing
- Antimicrobial protective coatings
- Filtration technologies
- Battery technology research
Research and Development Focus
Primary R&D concentrations include advanced materials for aerospace, healthcare, and electronics sectors.
Patent Portfolio
| Patent Category | Number of Patents |
|---|---|
| Graphene Technologies | 12 |
| Antimicrobial Coatings | 5 |
| Filtration Technologies | 3 |
Stock Performance
Trading on TSXV with average daily volume of approximately 500,000 shares. Stock price range in 2023: $0.30 - $0.75.
How Zentek Ltd. (ZTEK) Makes Money
Revenue Streams
Zentek Ltd. generates revenue through multiple technological sectors, with a primary focus on nanomaterials and graphene-based technologies.
| Revenue Source | Estimated Annual Revenue (2023) |
|---|---|
| Nanomaterial Technology Development | $1.2 million |
| Graphene Mask and Filter Technology | $750,000 |
| Research and Development Contracts | $500,000 |
Key Product Lines
- ZenGuard Antimicrobial Coating
- Graphene-enhanced Personal Protective Equipment
- Advanced Filtration Technologies
Technological Licensing
Zentek generates significant revenue through technology licensing agreements in multiple sectors including healthcare, aerospace, and industrial applications.
| Licensing Category | Licensing Revenue (2023) |
|---|---|
| Healthcare Technology | $425,000 |
| Industrial Applications | $350,000 |
| Aerospace Innovations | $275,000 |
Research and Development Funding
Zentek secures additional financial support through government and private research grants.
- Total R&D Grants in 2023: $1.5 million
- Government Research Funding: $900,000
- Private Research Investments: $600,000
Zentek Ltd. (ZTEK) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.